Back to results
US 2012/0251556 A1Published application
Combination Immunotherapy for the Treatment of Cancer
AssigneesBoard of Regents, The University of Texas System, Memorial Sloan Kettering Cancer Center
InventorsJames Allison, Padmanee Sharma, Sergio A. Quezada, Tihui Fu
Life of this patent
Estimating the term…
Abstract
Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-I, etc.) are demonstrated herein to be useful for the treatment of tumors.
Claims9
A method of treating cancer in a patient comprising administering to the patient simultaneously or sequentially a composition comprising a blocking agent to a T cell inhibitory receptor and an agonist to ICOS.
Dependencies are inferred from the claim text.